115 related articles for article (PubMed ID: 31729761)
1. How T'reg-ulate healing of the injured spinal cord?
Milling S; Edgar JM
Immunology; 2019 Dec; 158(4):253-254. PubMed ID: 31729761
[TBL] [Abstract][Full Text] [Related]
2. Sirtuin4 suppresses the anti-neuroinflammatory activity of infiltrating regulatory T cells in the traumatically injured spinal cord.
Lin W; Chen W; Liu W; Xu Z; Zhang L
Immunology; 2019 Dec; 158(4):362-374. PubMed ID: 31559637
[TBL] [Abstract][Full Text] [Related]
3. Programmed death protein 1 is essential for maintaining the anti-inflammatory function of infiltrating regulatory T cells in a murine spinal cord injury model.
He X; Lin S; Yang L; Tan P; Ma P; Qiu P; Zheng C; Zhang X; Kang W; Lin W
J Neuroimmunol; 2021 May; 354():577546. PubMed ID: 33744709
[TBL] [Abstract][Full Text] [Related]
4. Immune- and non-immune-mediated roles of regulatory T-cells during wound healing.
Zaiss DM; Minutti CM; Knipper JA
Immunology; 2019 Jul; 157(3):190-197. PubMed ID: 30866049
[TBL] [Abstract][Full Text] [Related]
5. FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance.
Dummer CD; Carpio VN; Gonçalves LF; Manfro RC; Veronese FV
Transpl Immunol; 2012 Jan; 26(1):1-10. PubMed ID: 21939765
[TBL] [Abstract][Full Text] [Related]
6. Methionine enkephalin (MENK) inhibits tumor growth through regulating CD4+Foxp3+ regulatory T cells (Tregs) in mice.
Li X; Meng Y; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
Cancer Biol Ther; 2015; 16(3):450-9. PubMed ID: 25701137
[TBL] [Abstract][Full Text] [Related]
7. INFα-2b inhibitory effects on CD4(+)CD25(+)FOXP3(+) regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts.
Yu Y; Huang R; Zong X; He X; Mo W
BMC Cancer; 2016 Jul; 16():397. PubMed ID: 27389040
[TBL] [Abstract][Full Text] [Related]
8. ICOS
Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H
Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099
[TBL] [Abstract][Full Text] [Related]
9. [
Qian-Qian Q; Xiao-Fan W; Li-Na Z; Li-Yang D; Ji-Feng Z; Xiao-Jun C; Zhi-Peng X; Ya-Lin L; Feng L; Sha Z; Chuan S
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2018 Feb; 30(1):42-46. PubMed ID: 29536706
[TBL] [Abstract][Full Text] [Related]
10. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
[TBL] [Abstract][Full Text] [Related]
11. Expression of IL-37 contributes to the immunosuppressive property of human CD4+CD25+ regulatory T cells.
Shuai X; Wei-min L; Tong YL; Dong N; Sheng ZY; Yao YM
Sci Rep; 2015 Sep; 5():14478. PubMed ID: 26411375
[TBL] [Abstract][Full Text] [Related]
12. Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.
Hiraki S; Ono S; Tsujimoto H; Kinoshita M; Takahata R; Miyazaki H; Saitoh D; Hase K
Surgery; 2012 Feb; 151(2):313-22. PubMed ID: 21982068
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid hormone treatment enhances the cytokine production of regulatory T cells by upregulation of Foxp3 expression.
Ugor E; Prenek L; Pap R; Berta G; Ernszt D; Najbauer J; Németh P; Boldizsár F; Berki T
Immunobiology; 2018; 223(4-5):422-431. PubMed ID: 29223294
[TBL] [Abstract][Full Text] [Related]
14. 'Repair' Treg Cells in Tissue Injury.
Zhang C; Li L; Feng K; Fan D; Xue W; Lu J
Cell Physiol Biochem; 2017; 43(6):2155-2169. PubMed ID: 29069643
[TBL] [Abstract][Full Text] [Related]
15. CD4+CD25+Foxp3+ regulatory T cells protect the proinflammatory activation of human umbilical vein endothelial cells.
He S; Li M; Ma X; Lin J; Li D
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2621-30. PubMed ID: 20930173
[TBL] [Abstract][Full Text] [Related]
16. Intense Foxp3+ CD25+ regulatory T-cell infiltration is associated with high-grade cutaneous squamous cell carcinoma and counterbalanced by CD8+/Foxp3+ CD25+ ratio.
Azzimonti B; Zavattaro E; Provasi M; Vidali M; Conca A; Catalano E; Rimondini L; Colombo E; Valente G
Br J Dermatol; 2015 Jan; 172(1):64-73. PubMed ID: 24910265
[TBL] [Abstract][Full Text] [Related]
17. Natural and inducible Tregs in swine: Helios expression and functional properties.
Käser T; Mair KH; Hammer SE; Gerner W; Saalmüller A
Dev Comp Immunol; 2015 Apr; 49(2):323-31. PubMed ID: 25511662
[TBL] [Abstract][Full Text] [Related]
18. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
[TBL] [Abstract][Full Text] [Related]
19. Analysis of murine and human Treg subsets in inflammatory bowel disease.
Sun X; He S; Lv C; Sun X; Wang J; Zheng W; Wang D
Mol Med Rep; 2017 Sep; 16(3):2893-2898. PubMed ID: 28677759
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD4+CD25+Foxp3+ Regulatory T Cells, Interleukin 10 and Transforming Growth Factor β in Newly Diagnosed Type 2 Diabetic Patients.
Yuan N; Zhang HF; Wei Q; Wang P; Guo WY
Exp Clin Endocrinol Diabetes; 2018 Feb; 126(2):96-101. PubMed ID: 28954308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
